| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |